Literature DB >> 10070956

Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status.

R G Syljuåsen1, B Krolewski, J B Little.   

Abstract

Recent studies have described a diminished radiation-induced G1 arrest in some wild-type (wt) p53 human tumor cell lines compared to normal human fibroblasts. However, the significance of this finding was unclear, particularly because tumor cell lines may have accumulated additional genetic changes after long periods in culture. Because malignant transformation of individual cells is thought to be an early step in carcinogenesis, we have used a model system of normal and transformed mouse fibroblast 10T1/2 cell clones to examine whether loss of G1 checkpoint control may be an early event in tumor development and to study the relationships between G1 arrest, radiosensitivity, and genetic alterations. Twelve transformed clones were established from type III foci induced by irradiation of normal 10T1/2 cells and were compared with six clones derived from wt 10T1/2 cells. Three of the transformed clones expressed mutant p53; two of these had the same point mutation at codon 132 (exon 5), and one had a point mutation at codon 135. The remaining transformed and normal clones had wt p53 status. The radiosensitivity of transformed clones, as measured by a clonogenic assay, was similar to that of normal clones; the three clones with mutant p53 did not differ from the others. There was no relationship between G1 arrest and radiosensitivity. Normal 10T1/2 cell clones showed a transient G1 arrest lasting approximately 9 h after 6 Gy of irradiation. This G1 arrest was either absent or markedly reduced in all of the transformed clones, regardless of p53 status. These results suggest that diminished G1 checkpoint control is an early event in the process of carcinogenesis that is associated with the malignant transformation of individual cells and is independent of p53 status.

Entities:  

Mesh:

Year:  1999        PMID: 10070956

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Role of the translationally controlled tumor protein in DNA damage sensing and repair.

Authors:  Jie Zhang; Sonia M de Toledo; Badri N Pandey; Guozheng Guo; Debkumar Pain; Hong Li; Edouard I Azzam
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency.

Authors:  Y E Whang; C Tran; C Henderson; R G Syljuasen; N Rozengurt; W H McBride; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth.

Authors:  Jeremy J Johnson; Sakina M Petiwala; Deeba N Syed; John T Rasmussen; Vaqar M Adhami; Imtiaz A Siddiqui; Amanda M Kohl; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2011-12-09       Impact factor: 4.944

4.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Authors:  N H Chehab; A Malikzay; M Appel; T D Halazonetis
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

5.  Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature.

Authors:  Anandh Balasubramaniam; Patrick Shannon; Mojgan Hodaie; Normand Laperriere; Howard Michaels; Abhijit Guha
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

6.  ATF4-dependent oxidative induction of the DNA repair enzyme Ape1 counteracts arsenite cytotoxicity and suppresses arsenite-mediated mutagenesis.

Authors:  Hua Fung; Pingfang Liu; Bruce Demple
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

7.  Kaiso is required for MTG16-dependent effects on colitis-associated carcinoma.

Authors:  Sarah P Short; Caitlyn W Barrett; Kristy R Stengel; Frank L Revetta; Yash A Choksi; Lori A Coburn; Mary K Lintel; Elizabeth M McDonough; M Kay Washington; Keith T Wilson; Egor Prokhortchouk; Xi Chen; Scott W Hiebert; Albert B Reynolds; Christopher S Williams
Journal:  Oncogene       Date:  2019-03-11       Impact factor: 9.867

8.  Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and Apoptosis.

Authors:  Roberto Vicinanza; Yanjun Zhang; Susanne M Henning; David Heber
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.